Search

Displaying results 1081 - 1090 of 10000 in total
  1. Drug

    Elranatamab

    go.drugbank.com/drugs/DB15395
    ApprovedInvestigational

    Elranatamab is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. It is a humanized immunoglobulin 2-alanine kappa antibody derived from two monoclonal antibodies (mAbs), an anti-BCMA mAb and an anti-CD3 mAb, each...

    Products: Elrexfio 44 mg/1,1 ml Enjeksiyonluk Çözelti, 1 ADET, Elrexfio 76 mg/1,9 ml Enjeksiyonluk Çözelti, 1 ADET
  2. Drug

    Levocabastine

    go.drugbank.com/drugs/DB01106
    Approved

    Levocabastine is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Levocabastine was discovered at Janssen Pharmaceutica in 1979.

    Products: Levocamed 0,5 mg/ml Augentropfensuspension, Levocamed 0,5 mg/ml Nasenspray, Suspension
  3. Drug

    Lomefloxacin

    go.drugbank.com/drugs/DB00978
    Approved

    Lomefloxacin is a fluoroquinolone antibiotic, used to treat bacterial infections including bronchitis and urinary tract infections (UTIs). Additionally, it has been employed for the prophylaxis of UTIs prior to surgery as well.

    Products: LOMFLOX TABLET 400 mg, OKACIN GOZ DAMLASI 3 MG/ML 5 ML
  4. Drug

    Olopatadine

    go.drugbank.com/drugs/DB00768
    Approved

    An ophthalmic solution of olopatadine was approved by the FDA and European Union for the treatment of seasonal and perennial allergic conjunctivitis in 1996 and 2002, respectively.

    Products: PALLADA-NS %6.65 MG/ML NAZAL SPREY, 30 ML, PALLADA-NS %6.65 MG/ML NAZAL SPREY, 15 ML
  5. Drug

    Darifenacin

    go.drugbank.com/drugs/DB00496
    ApprovedInvestigational

    Darifenacin blocks M3 muscarinic acetylcholine receptors, which mediate bladder muscle contractions. … It is unknown if M3 receptor selectivity is clinically advantageous in overactive bladder syndrome treatments.

    Products: Darifenacin 15 mg, Darifenacin 7.5 mg
  6. Drug

    Alendronic acid

    go.drugbank.com/drugs/DB00630
    ApprovedInvestigational

    Alendronic acid is a second generation bisphosphonate that is used for the treatment of some forms of osteoperosis and Paget's disease[FDA Label] . It functions by preventing resorption of bone[FDA Label] .

    Mixtures: BONMEGA 70 MG/2800 IU+1000 MG TEDAVI PAKETI, 4+24 ADET, Tridepos 70mg + 500 mg/800 I.E. TablettenProducts: ALENDRONATO DOC GENERICI, ALENDRONATO MYLAN GENERICS
  7. Drug

    Etamsylate

    go.drugbank.com/drugs/DB13483
    Investigational

    Products: DICYNONE INJECTION 250 mg/2 ml, DICYNONE® AMPOLLAS 250 MG
  8. Drug

    Lansoprazole

    go.drugbank.com/drugs/DB00448
    ApprovedInvestigational

    Lansoprazole marketed under the brand Prevacid, is a proton pump inhibitor (PPI) and is structurally classified as a substituted benzimidazole. It reduces gastric acid secretion by targeting gastric H,K-ATPase pumps and is thus effective...

    Mixtures: TRILEVO 500 MG+30 MG+ 1000 MG TEDAVİ PAKETİ, TRIO 1000 MG + 500 MG + 30 MG TEDAVİ PAKETİ, 6X7 ADETProducts: LANSOPRAZOLO MYLAN GENERICS, LANSOPRAZOLO MYLAN GENERICS ITALIA
  9. Drug

    T-2000

    go.drugbank.com/drugs/DB11654
    Investigational

    T2000 has been used in trials studying the treatment of Myoclonus and Essential Tremor.

  10. Drug

    BN-201

    go.drugbank.com/drugs/DB18295
    Investigational